Vivimed Labs Limited (VIVIMEDLAB) — Announcement

1 Announcement 🔴 High Importance ⚠️ Negative 📄 PDF

Vivimed Labs Limited has initiated a Corporate Insolvency Resolution Process (CIRP) as disclosed in a Form G filing on the NSE dated June 17, 2026. The filing outlines procedural timelines for expression of interest and resolution plan submissions, including key deadlines in late June and July 2026. It references manufacturing facilities across Telangana, Uttarakhand, and Karnataka, with preliminary unaudited financials and operational details. However, the document is heavily corrupted with typographical errors, fragmented text, and non-sequitur content, rendering most financial and legal details illegible. No audited financials or clear insolvency status are provided, and the filing includes warnings about advertiser risks. Investors should note the lack of reliable financial transparency and the procedural nature of this announcement amid significant data corruption.

2 Announcement 🔴 High Importance Neutral 📄 PDF

No summary available

📊 Stock Analysis — VIVIMEDLAB ✨ Ask AI About This